Inventor
WEHNER VOLKMAR
DE63 patents
⚠️ This page may combine multiple inventors who share the name “WEHNER VOLKMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOECHST AG
14 patentsUS5998447ADec 7, 1999
Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
HOECHST AG53 citations95
US6723727B1Apr 20, 2004
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
HOECHST AG26 citations92
US6514952B1Feb 4, 2003
Hydantoin derivatives as inhibitors of leucocyte adhesion and as VLA-4 antagonists
HOECHST AG22 citations92
US6005117ADec 21, 1999
Imino compounds, process for their preparation and their use as victronectin antagonists
HOECHST AG59 citations92
US5990145ANov 23, 1999
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG21 citations83
US6011045AJan 4, 2000
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG15 citations82
US5939556AAug 17, 1999
Hydantoin compounds, salts thereof, processes for their preparation, and processes for preparing pharmaceutically active compounds comprising them
HOECHST AG14 citations74
US6620820B2Sep 16, 2003
Inhibitors of bone reabsorption and antagonists of vitronectin receptors
HOECHST AG10 citations73
US6482821B2Nov 19, 2002
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG8 citations73
US6399620B1Jun 4, 2002
Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists
HOECHST AG8 citations73
US6218415B1Apr 17, 2001
Inhibitors or bone reabsorption and antagonists of vitronectin receptors
HOECHST AG11 citations73
US6218387B1Apr 17, 2001
Vitronectin receptor anatagonists, their preparation and their use
HOECHST AG10 citations73
US6867208B2Mar 15, 2005
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG1 citations63
US6387895B1May 14, 2002
Vitronectin receptor antagonists, their preparation and their use
HOECHST AG4 citations63
AVENTIS PHARMA GMBH
12 patentsUS6331552B1Dec 18, 2001
Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them
AVENTIS PHARMA GMBH21 citations92
US6906084B2Jun 14, 2005
Indole derivatives as factor Xa inhibitors
AVENTIS PHARMA GMBH30 citations90
US6667334B1Dec 23, 2003
Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
AVENTIS PHARMA GMBH18 citations84
US6838439B2Jan 4, 2005
Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists
AVENTIS PHARMA GMBH17 citations81
US6521654B2Feb 18, 2003
Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them
AVENTIS PHARMA GMBH8 citations74
US6423712B1Jul 23, 2002
2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
AVENTIS PHARMA GMBH6 citations74
US6759424B2Jul 6, 2004
Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them
AVENTIS PHARMA GMBH4 citations63
US6399643B1Jun 4, 2002
Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom
AVENTIS PHARMA GMBH5 citations63
US6933298B2Aug 23, 2005
Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases
AVENTIS PHARMA GMBH3 citations62
US6716853B2Apr 6, 2004
Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase
AVENTIS PHARMA GMBH2 citations62
US6962937B2Nov 8, 2005
Imidazolidine derivatives, their preparation and their use
AVENTIS PHARMA GMBH4 citations61
US6680333B2Jan 20, 2004
Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
AVENTIS PHARMA GMBH5 citations61
SANOFI AVENTIS DEUTSCHLAND
6 patentsUS7910606B2Mar 22, 2011
Pyrazole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND81 citations98
US7365088B2Apr 29, 2008
Indazole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND25 citations92
US7317027B2Jan 8, 2008
Azaindole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND26 citations92
US7196103B2Mar 27, 2007
Indole derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND27 citations92
US7465806B2Dec 16, 2008
Pyrrole-derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND18 citations84
US7358268B2Apr 15, 2008
Imidazole derivatives as factor Xa inhibitors
SANOFI AVENTIS DEUTSCHLAND2 citations51
HEINELT UWE
4 patentsUS9079906B2Jul 14, 2015
Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations51
US8853206B2Oct 7, 2014
Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations51
US8198272B2Jun 12, 2012
Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE0 citations51
US8076336B2Dec 13, 2011
Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
HEINELT UWE1 citations51
HOECHST SCHERING AGREVO GMBH
3 patentsUS5723450AMar 3, 1998
Substituted pyridines, their preparation, and their use as pesticides and fungicides
HOECHST SCHERING AGREVO GMBH21 citations84
US5877322AMar 2, 1999
Substituted pyridines, their preparation, and their use as pesticides and fungicides
HOECHST SCHERING AGREVO GMBH5 citations62
US5650417AJul 22, 1997
Substituted pyridines, their preparation, and their use as pesticides and fungicides
HOECHST SCHERING AGREVO GMBH2 citations62
SANOFI SA
3 patentsUS11130755B2Sep 28, 2021
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
SANOFI SA2 citations72
US12275733B2Apr 15, 2025
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
SANOFI SA0 citations62
US11827633B2Nov 28, 2023
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
SANOFI SA1 citations62
HOECHST MARION ROUSSEL INC
2 patentsUS6221907B1Apr 24, 2001
Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same
HOECHST MARION ROUSSEL INC16 citations83
US6194380B1Feb 27, 2001
Agents for promoting bone formation
HOECHST MARION ROUSSEL INC5 citations62
UCB BIOPHARMA SPRL
2 patentsHOECHST MARION ROUSSEL DE GMBH
1 patentAVENTIS PHARMA SA
1 patentHOECHST ATKIENGESELLSCHAFT
1 patentSANOFI AVENTIS
1 patentShowing the top 50 of 63 patents by PatentIndex Score.